05/01/2023–Comments on the Food and Drug Administration’s Discussion Paper on Artificial Intelligence in Drug Manufacturing [Docket No. FDA-2023-N-0487; 88 FR 12943]
CHI Comments re FDA Discussion Paper AI in Drug Manufacturing (050123)
On March 10, 2023, Representatives Miller-Meeks, Craig, and Murphy introduced legislation requiring the Food and Drug Administration (FDA) to conduct a study and issue recommendations on improving medical device data interoperability.
Brian Scarpelli, executive director of the Connected Health Initiative (CHI), expressed CHI’s support for the bill: “Interoperability is critical to realize the promise of digital health and enable better, more [...]
Healthcare and Technology Leaders Urge the 118th Congress to Continue the Promise of Digital Health
The Promise of Digital Health Exists, Connected Health Initiative Urges Congress to Achieve Potential January 31, 2023—Today, ACT | The App Association’s Connected Health Initiative (CHI) released its priorities for [...]
2023 CMS Physician Fee Schedule: Details, Takeaways and Our Thoughts
With the CMS Physician Fee Schedule issuance, details and takeaways are now available. Notably, consistent with our advocacy over the last few years urging CMS to make remote therapeutic monitoring [...]
Legislation introduced on requiring the FDA to study medical device data interoperability
On September 29, 2022, Representatives Miller-Meeks, O’Halleran, and Murphy introduced legislation requiring the Foodand Drug Administration (FDA) to conduct a study and issue recommendations on improving medical device data interoperability. [...]
